J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea
· Delayed Price · Currency is KRW 12,030
+720 (6.37%)
At close: Mar 26, 2025, 3:30 PM KST
J2KBIO Revenue
In the year 2024, J2KBIO had annual revenue of 33.13B KRW with 16.36% growth. J2KBIO had revenue of 6.76B in the quarter ending December 31, 2024, a decrease of -18.90%.
Revenue
33.13B
Revenue Growth
+16.36%
P/S Ratio
2.05
Revenue / Employee
602.35M
Employees
55
Market Cap
70.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.13B | 4.66B | 16.36% |
| Dec 31, 2023 | 28.47B | 12.44B | 77.60% |
| Dec 31, 2022 | 16.03B | 1.81B | 12.75% |
| Dec 31, 2021 | 14.22B | 360.95M | 2.60% |
| Dec 31, 2020 | 13.86B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Kia Corporation | 107.45T |
| Celltrion | 3,557.30B |
| KB Financial Group | 15.01T |